PDE6B and retinitis pigmentosa: Furthermore, stimulation of the mTOR pathway in mouse models of retinitis pigmentosa (Pde6b−/−, Pde6g−/− Rho−/− and Rho P23H) has been shown to prolong cone survival and may present as a potential treatment for patients with secondary cone degeneration [54].